IGC Pharma Inc (IGC)’s stock is trading at $0.35 at the moment marking a rise of 1.61% from the last session close. As of this writing, shares are priced at -26.46% less than their 52-week high of $0.48, and 39.80% over their 52-week low of $0.25.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, IGC’s SMA-200 is $0.3316.
Further, it is important to consider IGC stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 23.31.IGC’s price to book ratio for the most recent quarter was 4.51, resulting in an 72.22 price to cash per share for the period.
How does IGC Pharma Inc (IGC) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
IGC Pharma Inc (IGC): Earnings History
If we examine IGC Pharma Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$0.01, slashing the consensus of -$0.02. In other words, it beat the consensus by $0.01, resulting in a 50.00% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.01 in contrast with the Outlook of -$0.02. That was a difference of $0.01 and a surprise of 50.00%.
IGC Pharma Inc (AMEX: IGC) Ownership Details
I will give a breakdown of the key shareholders in IGC Pharma Inc (IGC). Recent figures show that the company’s insiders hold 9.16% of shares. A total of 26 institutional investors hold shares in the company, making 19.89% of its stock and 21.89% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Blackrock Inc. holding total of 703.8 shares that make 1.78% of the company’s total number of shares and are currently priced at 0.25 million.
The securities firm Geode Capital Management, LLC holds 700.01 shares of IGC, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.77% , and the holding percentage of shares is valued at 0.25 million.
An overview of IGC Pharma Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests IGC Pharma Inc (IGC) traded 7,593,042 shares per day, with a moving average of $0.3668 and price change of +0.0370. With the moving average of $0.3326 and a price change of +0.0157, about 3,185,223 shares changed hands on average over the past 50 days. Finally, IGC’s 100-day average volume is 1,716,515 shares, alongside a moving average of $0.3156 and a price change of +0.0119.
